A Reactive Oxygen Species and Proteasome Production Cycle in Renal Proximal Tubular Cells
Keywords:
Ubiquitin-proteasome system (UPS), Reactive oxygen species (ROS), Renal proximal tubular cellsAbstract
Aims
An intricate relationship exists between the mitochondrial function and proteasome activity. Our recent report showed in a rat model of renal transplantation that mitochondrial dysfunction precedes compromised proteasome function and this results in a vicious cycle of mitochondrial injury and proteasome dysfunction. In this study, we studied whether reactive oxygen species (ROS) has a role in proteasome alteration in renal cells and vice versa.
Methods
We used the genomic and pharmacologic approach on rat normal kidney proximal tubular (NRK) cell lines. First, we knocked down β5 or Rpt6 subunit of the proteasome using small interfering RNA (siRNA) in NRK cells. We also treated NRK cells with Bortezomib, a proteasome inhibitor, and peroxynitrite (a potent ROS).
Results
Studies with RNA interference showed increased mitochondrial ROS following knockdown of β5 or Rpt6 subunit in NRK cells. Similarly, pharmacological inhibition of the proteasome in NRK cells using Bortezomib also showed an increase of mitochondrial ROS in a dose-dependent manner. Next, exposing NRK cells to different concentrations of peroxynitrite provided evidence that the higher levels of peroxynitrite exposure decreased the key subunits (β5 and α3) of the proteasome in NRK cells.
Conclusion
Our results suggest that proteasome inhibition/downregulation increases ROS, which then impairs proteasome subunits in renal proximal tubular cells.
References
Eytan E, Ganoth D, Armon T, Hershko A. ATP-dependent in-corporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. Proc Natl Acad Sci U S A. 1989; 86(20): 7751-7755.
Voges D, Zwickl P, Baumeister W. The 26S proteasome: A molec-ular machine designed for controlled proteolysis. Annu Rev Biochem. 1999; 68: 1015-1068. doi: 10.1146/annurev.biochem.68.1.1015
Wilkinson KD. The discovery of ubiquitin-dependent prote-olysis. Proc Natl Acad Sci U S A. 2005; 102(43): 15280-15282. doi: 10.1073/pnas.0504842102
Fukasawa H. The role of the ubiquitin-proteasome system in kidney diseases. Clin Exp Nephrol. 2012; 16(4): 507-517. doi: 10.1007/s10157-012-0643-1
Pontrelli P, Oranger A, Barozzino M, Conserva F, Papale M, Gesualdo L. The pathological role of the ubiquitination pathway in diabetic nephropathy. Minerva Med. 2018; 109(1): 53-67. doi: 10.23736/S0026-4806.17.05419-2
Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006; 17(7): 1807-1819. doi: 10.1681/ASN.2006010083
Parajuli N, MacMillan-Crow LA. Role of reduced manganese su-peroxide dismutase in ischemia-reperfusion injury: a possible trig-ger for autophagy and mitochondrial biogenesis? Am J Physiol Renal Physiol. 2013; 304(3): F257-F267. doi: 10.1152/ajprenal.00435.2012
Kukan M. Emerging roles of proteasomes in ischemia-reperfu-sion injury of organs. J Physiol Pharmacol. 2004; 55(1): 3-15.
Livnat-Levanon N, Kevei E, Kleifeld O, et al. Reversible 26S proteasome disassembly upon mitochondrial stress. Cell Rep. 2014; 7(5): 1371-1380. doi: 10.1016/j.celrep.2014.04.030
Reinheckel T, Ullrich O, Sitte N, Grune T. Differential impair-ment of 20S and 26S proteasome activities in human hematopoi-etic K562 cells during oxidative stress. Arch Biochem Biophys. 2000; 377(1): 65-68. doi: 10.1006/abbi.2000.1717
Lo S, MacMillan-Crow LA, Parajuli N. Renal cold storage fol-lowed by transplantation impairs proteasome function and mi-tochondrial protein homeostasis. Am J Physiol Renal Physiol. 2019; 316(1): F42-F53. doi: 10.1152/ajprenal.00316.2018
Adams J. Development of the proteasome inhibitor PS-341. Oncologist. 2002; 7(1): 9-16.
Kisselev AF, van der Linden WA, Overkleeft HS. Proteasome inhibitors: An expanding army attacking a unique target. Chem Biol. 2012; 19(1): 99-115. doi: 10.1016/j.chembiol.2012.01.003
Mitchell T, Saba H, Laakman J, Parajuli N, MacMillan-Crow LA. Role of mitochondrial-derived oxidants in renal tubular cell cold-storage injury. Free Radic Biol Med. 2010; 49(8): 1273-1282. doi: 10.1016/j.freeradbiomed.2010.07.012
Song IS, Kim HK, Lee SR, et al. Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells. Int J Cancer. 2013; 133(6): 1357-1367. doi: 10.1002/ijc.28149
Stankova K, Ivanova K, Nikolov V, Aneva N, Georgieva R, Boteva R. Proteasome inhibition protects human peripheral blood mononuclear cells from radiation-induced oxidative stress. Int J Ra-diat Biol. 2013; 89(7): 493-500. doi: 10.3109/09553002.2013.782451
Dreger H, Westphal K, Weller A, et al. Nrf2-dependent upregu-lation of antioxidative enzymes: A novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc Res. 2009; 83(2): 354-361. doi: 10.1093/cvr/cvp107
Maharjan S, Oku M, Tsuda M, Hoseki J, Sakai Y. Mitochondrial impairment triggers cytosolic oxidative stress and cell death fol-lowing proteasome inhibition. Sci Rep. 2014; 4: 5896. doi: 10.1038/ srep05896
Davies KJ. Degradation of oxidized proteins by the 20S protea-Submit your article to this journal | https://openventio.org/submit-manuscript/ Parajuli N some. Biochimie. 2001; 83(3-4): 301-310.
Dal Vechio FH, Cerqueira F, Augusto O, Lopes R, Demasi M. Peptides that activate the 20S proteasome by gate opening increased oxidized protein removal and reduced protein aggrega-tion. Free Radic Biol Med. 2014; 67: 304-313. doi: 10.1016/j.freerad-biomed.2013.11.017
Hohn A, Konig J, Grune T. Protein oxidation in aging and the removal of oxidized proteins. Journal of Proteomics. 2013; 92: 132- 159. doi: 10.1016/j.jprot.2013.01.004
Grune T, Catalgol B, Licht A, et al. HSP70 mediates dissocia-tion and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic Biol Med. 2011; 51(7): 1355-1364. doi: 10.1016/j.freeradbiomed.2011.06.015
Djakovic SN, Marquez-Lona EM, Jakawich SK, et al. Phos-phorylation of Rpt6 regulates synaptic strength in hippocampal neurons. J Neurosci. 2012; 32(15): 5126-5131. doi: 10.1523/JNEU-ROSCI.4427-11.2012
Day SM, Divald A, Wang P, et al. Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure. Circ Heart Fail. 2013; 6(3): 544-549. doi: 10.1161/ CIRCHEARTFAILURE.112.000119
Satoh K, Sasajima H, Nyoumura KI, Yokosawa H, Sawada H. Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. Biochemistry. 2001; 40(2): 314- 319.
Schmidt M, Finley D. Regulation of proteasome activity in health and disease. Biochim Biophys Acta. 2014; 1843(1): 13-25. doi: 10.1016/j.bbamcr.2013.08.012
Scruggs SB, Zong NC, Wang D, Stefani E, Ping P. Post-transla-tional modification of cardiac proteasomes: Functional delineation enabled by proteomics. Am J Physiol Heart Circ Physiol. 2012; 303(1): H9-H18. doi: 10.1152/ajpheart.00189.2012
Wang X, Pattison JS, Su H. Posttranslational modification and quality control. Circ Res. 2013; 112(2): 367-381. doi: 10.1161/CIR-CRESAHA.112.268706
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Toxicology and Forensic Medicine (TFM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
